Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer
- Paz-Ares, L.G.
- Biesma, B.
- Heigener, D.
- Von Pawel, J.
- Eisen, T.
- Bennouna, J.
- Zhang, L.
- Liao, M.
- Sun, Y.
- Gans, S.
- Syrigos, K.
- Le Marie, E.
- Gottfried, M.
- Vansteenkiste, J.
- Alberola, V.
- Strauss, U.P.
- Montegriffo, E.
- Ong, T.J.
- Santoro, A.
ISSN: 0732-183X, 1527-7755
Année de publication: 2012
Volumen: 30
Número: 25
Pages: 3084-3092
Type: Article